期刊文献+

急性白血病血管内皮生长因子的含量及临床意义 被引量:1

Serum level of vascular endothelial growth factor in children with acute leukemia
下载PDF
导出
摘要 目的 检测急性白血病病人外周静脉血血管内皮生长因子 (vascularendothelialgrowthfactor ,VEGF)的含量并探讨其临床意义。方法 采用酶联免疫吸附方法 ,测定 5 2例急性白血病病人和 2 1例健康查体者外周静脉血VEGF含量。结果 急性白血病初发未治组血清VEGF含量明显高于正常对照组及缓解组 (t值分别为 3.2 9,3.4 9,均P <0 .0 1) ;而缓解组与正常对照组比较差异无显著性意义 (t =0 .79,P >0 .0 5 )。急性淋巴细胞性白血病 (ALL)与急性非淋巴细胞白血病 (ANLL)比较VEGF含量无差别 (t =0 .5 5 ,P >0 .0 5 )。VEGF高水平组比低水平组病死率高 (χ2 =9.75 ,P <0 .0 5 )。初发未治ALL组VEGF含量与诱导缓解所需时间呈高度正相关(r =0 .93,P <0 .0 1)。结论 初发未治组VEGF含量显著高于缓解组及对照组 ,高水平VEGF存在高病死率 ,在ALL病人中 ,VEGF水平与化疗达完全缓解所需时间呈高度正相关。
出处 《中国当代儿科杂志》 CAS CSCD 2003年第4期351-352,共2页 Chinese Journal of Contemporary Pediatrics
  • 相关文献

参考文献8

  • 1刘洪涛.血管生成、血管内皮生长因子与恶性血液病[J].国外医学(输血及血液学分册),2001,24(2):120-123. 被引量:1
  • 2梁爱斌,顾龙君.血管内皮生长因子及其受体与血液系统恶性肿瘤[J].中国当代儿科杂志,2002,4(5):427-430. 被引量:1
  • 3Katoh O, Tauchi H, Kawaishi K, et al. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation [J]. Cancer Res, 1995, 55(23) : 5687 - 5692.
  • 4Vacca A, Ribatti D, Iurlaro M, et al. Human lymphoblastoid cells produce extracellular natrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis [J]. Int J Clin Lab Res, 1998, 28(1): 55-68.
  • 5Crew JP, O' Brien T, Endo H, et al. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates [J]. J Urol, 1999, 161(3): 799-804.
  • 6Perez-Atayde AR, Sallan SE, Tedrow U, et al. Spectrum of tumor angiogenesis in the Bone Marrow of children with acute lymphoblastic leukemia [J]. Am J Pathol, 1997, 150(3): 815 -821.
  • 7Fiedler W, Graeven U, Ergun S, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia [J]. Blood, 1997, 89(6): 1870- 1875.
  • 8Aguayo A, Estey E, Kantarjian H, et al. Cellular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia [J]. Blood, 1999, 94(11): 3717-3721.

二级参考文献47

  • 1Katoh O, Tauchi H, Kawaishi K, et al. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res, 1995, 55(23): 5687-5692.
  • 2Vacca A, Ribatti D, Iurlaro M, et al. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res, 1998, 28(1): 55-68.
  • 3Mangi MH, Newland AC. Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol, 2000, 111(1): 43-51.
  • 4Helen Turley, Prudence A, Victoria M, et al. Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. Journal of pathology, 1998, 186(2): 313-318.
  • 5Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res, 1999, 59(3): 728-733.
  • 6Aguayo A, Manshouri T, O'Brien S, et al. Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL). Leuk Res, 2001, 25(4): 279-85.
  • 7Mesters RM, Padro T, Steins M, et al. Angiogenesis in patients with hematologic malignancies. Onkologi, 2001, 24 (Suppl 5): 75-80.
  • 8Koistinen P, Siitonen T, Mantymaa P, et al. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system. Leukemia, 2001, 15(9): 1433-1441.
  • 9Hayashibara T, Yamada Y, Miyanishi T, et al. Vascular endothelial growth factor and cellular chemotaxis: a possible Autocrine pathway in adult T-cell leukemia cell invasion. Clin Cancer Res, 2001, 7(9): 2719-2726.
  • 10Masood R, Gordon EM, Whitley MD, et al. Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors. Int J Mol Med, 2001, 8(4): 335-343.

同被引文献13

  • 1Hayashibara T, Yamada Y, Miyanishi T, Mori H, Joh T, Maeda T, et al. Vascular Endothelial Growth Factor and Cellular Chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion [J]. Clin Cancer Res, 2001, 7(9): 2719-2726.
  • 2Hanahan D, Weinberg RA. The hallmarks of cancer [J]. Cell, 2000,100(1): 57-70.
  • 3Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis[J]. Cell Struct Funct, 2001, 26(1): 25-35.
  • 4Gupta M, Mungai PT, Goldwasser E. A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene [J]. Blood, 2000, 15, 96(2): 491-497.
  • 5Wellmann S, Guschmann M, Griethe W, Eckert C, von Stackelberg A, Lottaz C, et al. Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF [J]. Leukemia, 2004, 18(5): 926-933.
  • 6Niitsu N, Okamato M, Nakamine H, Yoshino T, Tamaru J, Nakamura S, et al. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggression non-Hodgkin′s lymphoma [J]. Eur J Haematol, 2002, 68(2): 91-100.
  • 7Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptor in hematopoietic malignancies [J]. Cancer Research, 1999, 59(3): 728-733.
  • 8Padro T, Bieker R, Ruiz S, Steins M, Retzlaff S, Burger H, et al. Overexpression of vascular endothelial growth factor (VEGF) and its celluar receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia [J]. Leukemia, 2002, 16(7): 1302-1310.
  • 9Koomagi R, Zintl F, Sauerbrey A, Volm M. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction [J]. Clin Cancer Res, 2001, 7(11): 3381-3384.
  • 10Bairey O, Boycov O, Kaganovsky E, Zimra Y, Shaklai M, Rabizadeh E. All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells [J]. Leuk Res, 2004, 28(3): 243-248.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部